Two Sigma Investments’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,745
| Closed | -$67.1K | – | 3198 |
|
|
2025
Q1 | $67.1K | Sell |
13,745
-5,637
| -29% | -$33.9K | ﹤0.01% | 3010 |
|
|
2024
Q4 | $162K | Sell |
19,382
-3,123
| -14% | -$27.3K | ﹤0.01% | 2902 |
|
|
2024
Q3 | $234K | Sell |
22,505
-22,894
| -50% | -$381K | ﹤0.01% | 2762 |
|
|
2024
Q2 | $894K | Sell |
45,399
-93,303
| -67% | -$1.87M | ﹤0.01% | 2050 |
|
|
2024
Q1 | $3.55M | Sell |
138,702
-6,839
| -5% | -$175K | 0.01% | 1158 |
|
|
2023
Q4 | $4.02M | Buy |
+145,541
| New | +$8.87M | 0.01% | 1107 |
|
|
2023
Q3 | – | Sell |
-8,430
| Closed | -$555K | – | 2963 |
|
|
2023
Q2 | $555K | Buy |
+8,430
| New | +$617K | ﹤0.01% | 2286 |
|
|
2022
Q3 | – | Sell |
-25,777
| Closed | -$2.13M | – | 2485 |
|
|
2022
Q2 | $2.13M | Sell |
25,777
-15,205
| -37% | -$1.18M | 0.01% | 1166 |
|
|
2022
Q1 | $3.98M | Buy |
40,982
+32,447
| +380% | +$4.28M | 0.01% | 1025 |
|
|
2021
Q4 | $1.71M | Buy |
+8,535
| New | +$2.01M | ﹤0.01% | 2069 |
|
|
2021
Q2 | – | Sell |
-17,664
| Closed | -$6.9M | – | 4055 |
|
|
2021
Q1 | $6.9M | Buy |
17,664
+16,731
| +1,793% | +$8.24M | 0.02% | 884 |
|
|
2020
Q4 | $523K | Sell |
933
-3,717
| -80% | -$2.36M | ﹤0.01% | 2485 |
|
|
2020
Q3 | $3.25M | Buy |
+4,650
| New | +$3.63M | 0.01% | 1021 |
|
|
2020
Q2 | – | Sell |
-10,046
| Closed | -$5.98M | – | 2960 |
|
|
2020
Q1 | $5.98M | Buy |
+10,046
| New | +$9.79M | 0.05% | 428 |
|
|
2019
Q3 | – | Sell |
-2,330
| Closed | -$3.84M | – | 3458 |
|
|
2019
Q2 | $3.84M | Buy |
+2,330
| New | +$4.03M | 0.01% | 1034 |
|
|
2019
Q1 | – | Sell |
-19,708
| Closed | -$25.3M | – | 3026 |
|
|
2018
Q4 | $25.3M | Buy |
+19,708
| New | +$30.2M | 0.1% | 271 |
|
|
2018
Q1 | – | Sell |
-6,752
| Closed | -$15.6M | – | 3155 |
|
|
2017
Q4 | $15.6M | Buy |
6,752
+188
| +3% | +$382K | 0.05% | 438 |
|
|
2017
Q3 | $11.7M | Buy |
+6,564
| New | +$9.17M | 0.04% | 462 |
|
|
2015
Q3 | – | Sell |
-14,939
| Closed | -$32.6M | – | 2217 |
|
|
2015
Q2 | $32.6M | Buy |
14,939
+14,638
| +4,863% | +$29.8M | 0.15% | 167 |
|
|
2015
Q1 | $471K | Sell |
301
-795
| -73% | -$1.05M | ﹤0.01% | 2013 |
|
|
2014
Q4 | $1.3M | Buy |
+1,096
| New | +$732K | 0.01% | 1247 |
|
|
2014
Q3 | – | Sell |
-818
| Closed | -$409K | – | 1758 |
|
|
2014
Q2 | $409K | Buy |
+818
| New | +$262K | ﹤0.01% | 1707 |
|
Other funds holding BLUE
Two Sigma Investments's BLUE Position: Q2 2025 in Review
Two Sigma Investments sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 13,745 shares — an estimated $67.1K sold.
Two Sigma Investments first reported a position in BLUE in Q2 2014 and held it in 22 quarters. The position peaked at $32.6M in Q2 2015. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Two Sigma Investments reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Two Sigma Investments sold 13,745 bluebird bio shares in Q2 2025, an estimated $67.1K.
- Two Sigma Investments first reported a position in bluebird bio in Q2 2014 and held it in 22 quarters.
- Two Sigma Investments's bluebird bio position peaked at $32.6M in Q2 2015.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.